1,860
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Development of thermo-sensitive injectable hydrogel with sustained release of doxorubicin: Rheological characterization and in vivo evaluation in rats

, , , , &
Pages 305-311 | Received 25 Aug 2010, Accepted 30 Nov 2010, Published online: 12 Jan 2011

References

  • Álvarez-Cedrón, L., Sayalero, M.L., Lanao, J.M. (1999). High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues. J Chromatogr. 721:271–8.
  • Arnold, R., Slack, J.E., Straubinger, R.M. (2004). Quantification of Doxorubicin and metabilites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy. J Chromatogr B. 808:141–52.
  • Bhattarai, N., Ramay, H.R., Gunn, J., Matsen, F.A., Zhang, M. (2005). PEG-grafted chitosan as an injectable thermo-sensitive hydrogel for sustained protein release. J Contr Rel. 103:609–24.
  • Cabana, A., Ait-kadi, A., Juhasz, J. (1997). Study of the gelation process of polyethylene oxide-polypropylene oxide-polyethylene oxide copolymer (poloxamer 407) aqueous solution. J Colloid Interface Sci. 190:307–12.
  • Choi, H.G., Jung, J.H., Ryu, J.M., Yoon, S.J., Sung Oh, Y.K., Kim, C.K. (1998a). Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm. 165:33–44.
  • Choi, H.G., Kim, M.H., Lee, M.K., Kim, C.K. (1999). Effect of additives on the physicochemical properties of liquid suppository. Int J Pharm. 190:13–19.
  • Choi, H.G., Oh, Y.K., Kim, C.K. (1998b). In-situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int J Pharm. 165;23–32.
  • Dumortier, G., Zumer, M., Courarraze, G., Chaumeil, J.C., Grossiord, J.L. (1991). Rheological study of a thermoreversible morphine gel. Drug Dev Ind Pharm. 17:1255–65.
  • Fan, H., Dash, A.K. (2001). Effect of cross-linking on the in vitro release kinetics of doxorubicin from gelatin implants. Int J Pharm. 213:103–16.
  • Fundarò, A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G.P., Gasco, M.R. (2000). Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. Pharm Res. 42:337–43.
  • Gibaldi, M., Perrier, D. (1982). Pharmacokinetics. 2nd ed. New York: Marcel-Dekker.
  • Jeong, B., Gutowska, A. (2002). Lessons from nature: stimuli-responsive polymers and their biomedical applications. Trends Biotechnol. 20:305–11.
  • Kakinoki, S., Taguchi, T., Saito, H., Tanaka, J., Tateishi, T. (2007). Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: characterization and in vitro evaluation. Eur J Pharm Biopharm. 66:383–90.
  • Kang, G.D., Cheon, S.H., Khang, G., Song, S.C. (2006b). Thermo-sensitive poly (organophosphazene) hydrogels for a controlled drug delivery. Eur J Pharm Biopharm. 63:340–6.
  • Kang, G.D., Cheon, S.H., Song, S.C. (2006a). Controlled release of doxorubicin from thermosensitive poly(organophosphazene) hydrogels. Int J Pharm. 319:29–36.
  • Klein-Szanto, A.J. (1992). Carcinogenic effects of chemotherapeutic compounds. Prog Clin. 374:167–74.
  • Lee, S.Y., Tae, G. (2007). Formulation and in vitro characterization of an in situ gelable, photo-polymerizable Pluronic hydrogel suitable for injection. J Contr Rel. 119:313–9.
  • Lenarets, V., Triqueneaux, C., Quarton, M., Falson, F.R., Couvreur, P. (1987). Temperature-dependent rheological behavior of Pluronic F-127 aqueous solutions. Int J Pharm. 31:121–7.
  • Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., Gianni, L. (2004). Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 56:185–229.
  • Paavola, A., Kilpeläinen, I., Yliruusi, J., Rosenberg, P. (2000). Controlled release injectable liposomal gel of ibuprofen for epidural analgesia. Int J Pharm. 199:85–93.
  • Raymond, J., Metcalfe, A., Salazkin, I., Schwarz, A. (2004). Temporary vascular occlusion with poloxamer 407. Biomaterials. 25:3983–9.
  • Ricci, E.J., Bentley, M.V., Farah, M., Bretas, R.E., Marchetti, J.M. (2002). Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels. Eur J Pharm Sci. 17:161–7.
  • Schmolka, I.R. (1972). Artificial skin I. Preparation and properties of Pluronic F-127 gels for treatment of burns. J Biomed Mat Res. 6:571–82.
  • Society of Toxicology (SOT), December. (2008). Guiding principles in the use of animals in toxicology. Available online at: www.toxicology.org/AI/FA/guidingprinciples.pdf, accessed
  • Tan, E.C., Lin, R., Wang, C.H. (2005). Fabrication of double-walled microspheres for the sustained release of doxorubicin. J Colloid Interf Sci. 291:135–43.
  • Veyries, M.L., Couarraze, G., Geiger, S., Agnely, F., Massias, L., Kunzli, B., Faurisson, F., Rouveix, B. (1999). Controlled release of vancomycin from poloxamer 407 gels. Int J Pharm. 192:183–93.
  • Yong, C.S., Choi, J.S., Quan, Q.Z., Rhee, J.D., Kim, C.K., Lim, S.J., Kim, K.M., Choi, H.G. (2001). Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int J Pharm. 226:195–205.
  • Yong, C.S., Yang, C.H., Rhee, J.D., Lee, B.J., Kim, D.C., Kim, D.D., Kim, C.K., Choi, J.S., Choi, H.G. (2004). Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol. Int J Pharm. 269:169–76.
  • Yun, M.O., Choi, H.G., Jung, J.H., Kim, C.K. (1999). Development of thermoreversible insulin liquid suppository with sodium salicylate. Int J Pharm. 189:137–45.
  • Zhao, P., Dash, A.K. (1999). A simple HPLC method using a microbore column for the analysis of doxorubicin. J Pharmaceut Biomed. 20:543–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.